CME Matters.png
Any trouble registering? Contact us to help:  eyecare-events@ubm.com

 

Please join us at this important and exciting CME-accredited meeting focused on current and emerging gene therapy options for inherited retinal disease (IRD). This educational symposium will discuss the safety and efficacy of varied approaches to gene therapy across the spectrum of IRD. A real-world experience simulating the challenges faced by people living with IRD will be included.

There is no fee to attend this meeting.

This event is not organized or sponsored by ARVO.

Meeting Details:

Title:  Brave New World: Gene Therapy for Inherited Retinal Disease
A CME-Accredited Dinner Symposium

Date:  Saturday, April 28, 2018

Time:  Registration and Dinner begins at 5:30pm
              Program 6:00pm-8:00pm

Location:  Hilton Hawaiian Village Resort
                      2005 Kalia Road, Honolulu

 

Guest Speakers:

Bart P. Leroy, MD, PhD (Chair)
Head of Department & Chairman
Department of Ophthalmology
Staff Member, Center for Medical Genetics Ghent
Associate Professor, Ophthalmic Genetics & Visual Electrophysiology
Ghent University & Ghent University Hospital

 

Mark Pennesi MD, PhD
Division Chief, Ophthalmic Genetics
Associate Professor of Ophthalmology
School of Medicine
Oregon Health and Science University

 

Shannon E. Boye, PhD
Associate Professor
Department of Ophthalmology
University of Florida

 

We look forward to seeing you in Hawaii!

 

Please direct any questions about the program to cpagano@cmematters.org

 

IMPORTANT DISCLAIMER

Registering in advance for this meeting provides you with a higher priority of admittance. We ask that you arrive no later than 5:20pm to ensure a spot at this important meeting. After this time, onsite registrants will be granted admission on a first-come, first-serve basis.

 

Additional Info:

This CME-accredited program is sponsored by the Institute for Continuing Healthcare Education, in partnership with Ophthalmology Times. Icpagano@cmematters.org is being funded by an unrestricted education grant from Spark Therapeutics.